Digital Personalized Nutrition Market to Reach USD 1.57 Billion by 2029, Subscription Purchase Model to Dominates, APAC Takes Center Stage – Arizton

“Digital Personalized Nutrition Research Report by Arizton”

 

According to Arizton’s latest research report, the digital personalized nutrition market is growing at a CAGR of 17.75% from 2023 to 2029.   

 

To Know More, Click: https://www.arizton.com/market-reports/digital-personalized-nutrition-market 

The adoption rate of digital personalized nutrition products among end-users in the US and Europe has been impressive since their launch. The competition among companies is intensifying, which will lead to the introduction of many innovative and advanced solutions in the market soon. These players compete based on various factors such as price, availability, brand, and variety. However, the price is set to become a significant factor for competition among players to gain an edge over other vendors in the market. Furthermore, the market players’ growth depends on their condition, GDP growth, and industry development. High capital requirements and rapid technological advances are significant entry barriers for new players. Therefore, market vendors must attain sustainability, expand into other geographies, and revive domestic demand.  

 

Subscription Purchase Model to Contribute the Largest Share in the Market 

The subscription-based digital personalized nutrition model is well-suited for people looking for a continuous and comprehensive approach to their health and nutrition journey. While the one-time purchase model offers flexibility, the subscription model provides a more immersive and ongoing relationship with personalized nutrition services, aligning with individuals’ changing needs and preferences dedicated to long-term well-being. 

Subscribers with their personalized nutrition platform  benefit from a continual and evolving relationship. The recurring nature of the subscription enables continuous improvement of the nutrition plan, encompassing updated health metrics and preferences. The ease of regular payments ensures continuing access to mobile applications, digital tools, and other technology-driven solutions that enable collecting and analyzing health data, contributing to the dynamic nature of the personalized nutrition service. 

 

APAC Leading the Digital Personalized Nutrition Market 

The APAC digital personalized nutrition market will reach $373 million by 2029.   

Increasing consumer health awareness, a deeper understanding of health and fitness, and the rising adoption of digital healthcare are vital drivers propelling growth in the digital personalized nutrition market across the APAC region. Factors such as inadequate nutrition, escalating nutrition-related disorders, and a growing elderly population are also fueling retail sales of nutrition and health products. There is an opportunity for businesses to enhance their services by promoting awareness of healthy eating habits, embracing personalized plans, and integrating health-tracking devices. These advancements aid in diagnosing and monitoring health parameters, enabling individuals to meet their nutritional needs. Consumers increasingly gravitate towards scientifically backed and data-driven solutions to align with their health objectives. Notably, the region has experienced substantial growth driven by shifts in lifestyle patterns and heightened health consciousness. Nevertheless, the expenses associated with nutrition programs and dietary supplements pose potential challenges to developing the digital personalized nutrition market in the region. Additionally, limited adoption of data-driven technologies and innovations may present hurdles to market expansion. 

 

Recent Developments in the Global Digital Personalized Nutrition Market 

  • Noom has introduced a new “family plan” option, which enables multiple family members to share personalized coaching and recommendations, promoting healthy habits and community within the household. 

  • Noom launched a program particularly personalized for managing pre-diabetes and preventing type 2 diabetes, leveraging data analysis to foresee and to avoid blood sugar spikes. 

  • Viome acquired Naring Health, a digital health and wellness company, in 2023 to expand its offering for continuous early disease detection, health monitoring, and personalized care into its services. 

  • Viome introduced Gut Intelligence Plus, a new program combining their core Gut Intelligence test with ongoing blood sugar monitoring, sleep patterns, and inflammatory markers. This provides a real-time picture of a person’s responses to diet and lifestyle changes, allowing for continuous modifications to personalized recommendations. 

  • InsideTracker (Segterra) partnership with Garmin, this collaboration integrated InsideTracker’s insights with Garmin’s wearables and fitness trackers. Consumers can connect their Garmin devices to InsideTracker, which enables seamless data transfer and a more inclusive view of their health and performance. 

 

Buy this Research @ https://www.arizton.com/market-reports/digital-personalized-nutrition-market 

Post-Purchase Benefit                         

  • 1hr of free analyst discussion                        

  • 10% off on customization      

Key Company Profiles 

  • Nutrigenomix 

  • 23andMe 

  • Viome 

  • Noom 

  • Atlas Biomed 

  • DayTwo 

  • CircleDNA 

  • Ancestry 

  • Second Nature 

  • Care/of 

  • Segterra 

  • Persona 

  • BiogeniQ 

  • Baze 

  • Nutrisense 

  • Rootine 

  • HealthifyMe 

  • Caligenix 

  • GenoPalate 

  • Habit Food, Personalized 

  • Levels 

  • Culina Health 

  • Sirka 

  • Lifesum 

  • Foodvisor 

  • Nutrium 

 

Market Segmentation  

Purchase Model 

  • Subscription 

  • One Time Purchase 

End-Users 

  • Direct Consumers 

  • Wellness & Fitness Centers 

  • Hospitals & Clinics 

  • Institutions 

Application 

  • Generic Health & Fitness 

  • Disease Based 

  • Sports Nutrition 

Geography 

  • North America 

  • The US 

  • Canada 

  • Europe 

  • Germany 

  • The UK 

  • France 

  • Italy 

  • Spain 

  • Netherlands 

  • Sweden 

  • APAC 

  • China 

  • Japan 

  • South Korea 

  • India 

  • Australia 

  • Singapore 

  • Indonesia 

  • Latin America 

  • Brazil 

  • Mexico 

  • Colombia 

  • Middle East & Africa 

  • South Africa 

  • The UAE 

  • Saudi Arabia 

  • Turkey 

 

Key Questions Answered in the Report:     

How big is the digital personalized nutrition market? 

What is the growth rate of the global digital personalized nutrition market? 

Which region dominates the global digital personalized nutrition market share? 

What are the significant trends in the digital personalized nutrition market? 

Who are the key players in the global digital personalized nutrition market? 

 

Check Out Some of the Top Selling Research Reports:         

Parenteral Nutrition Market – Global Outlook and Forecast 2022-2027 

U.S. Clinical Nutrition Market – Industry Outlook & Forecast 2022-2027 

Personalized Nutrition Market – Global Outlook and Forecast 2023-2028 

Nutraceuticals Market – Global Outlook & Forecast 2023-2028 

 

Why Arizton?                  

100% Customer Satisfaction                  

24×7 availability – we are always there when you need us                  

200+ Fortune 500 Companies trust Arizton’s report                  

80% of our reports are exclusive and first in the industry                  

100% more data and analysis                  

1500+ reports published till date                   

 

About Us:                                                       

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                     

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                      

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                            

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1-312-235-2040.+1 302 469 0707      
Country: United States
Website: https://www.arizton.com/market-reports/digital-personalized-nutrition-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Digital Personalized Nutrition Market to Reach USD 1.57 Billion by 2029, Subscription Purchase Model to Dominates, APAC Takes Center Stage – Arizton

Thermoplastic Polyolefin Market Forecasted to Reach $7.3 Billion by 2028| MarketsandMarkets™

“Browse 225 market data Tables and 44 Figures spread through 219 Pages and in-depth TOC on “Thermoplastic Polyolefin Market””
The Thermoplastic Polyolefin (TPO) market is experiencing robust growth due to its applications in automotive, construction, and packaging industries. TPOs offer benefits like durability, flexibility, and recyclability, driving their increasing demand.

The Thermoplastic polyolefin Market is projected to reach USD 7.3 Billion by 2028, at a CAGR of 6.0% from USD 5.4 Billion in 2023. The increasing demand from the end use industries such as automotive, construction, electronics appliances, and others contribute to the rapid growth in the demand for the Thermoplastic polyolefin market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256331319  

Based on type, the Thermoplastic polyolefin market has been segmented into In situ TPO, Compounded TPO and Polyolefin elastomers (POEs). The POEs segment is the largest market share in value during the forecast period as it offers wide and different applications in various industries. POEs are used in various automotive components due to their durability, weather resistance, and ability to withstand temperature extremes. Examples include gaskets, seals, weather stripping, and vibration dampeners.

Based on application,  In terms of value, the global Thermoplastic polyolefin market is divided into automotive, building & construction, medical, wire and cables, and others. The automotive industry is the largest segment of the thermoplastic polyolefin (TPO) market primarily due to the critical need for lightweighting in modern vehicles. TPOs offer an excellent balance of properties, including high strength, low density, and good impact resistance, making them ideal for automotive applications.  

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=256331319 

Based on Region, The Asia-Pacific region stands as the largest market for thermoplastic polyolefins (TPOs) owing to a confluence of factors. Firstly, the rapid expansion of the automotive industry in countries like China and India has fueled substantial demand for TPOs in the manufacturing of lightweight, cost-effective automotive components. Secondly, the region is experiencing a construction boom driven by urbanization and economic growth, with TPOs being favored for applications such as roofing membranes and waterproofing materials. Additionally, TPOs find widespread use in consumer goods, packaging, and industrial applications across Asia-Pacific, further solidifying the region’s dominance in the TPO market.

The key players in the Thermoplastic polyolefin market are DOW (US), Mitsui Chemical, Inc. (Japan), Exxon Mobil Corporation (Texas), SABIC (Saudi Arabia), Sumitomo Chemicals Co., Ltd. (Japan), LyondellBasell Industries N.V. (Texas), Ineos Group Holdings SA (Switzerland), Borealis AG (Austria), Formosa Plastic Corporation (Taiwan), RTP Company (US). and others.

Inquire Now: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=256331319 

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/thermoplastic-polyolefin-market-256331319.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Thermoplastic Polyolefin Market Forecasted to Reach $7.3 Billion by 2028| MarketsandMarkets™

Sustainability Drive and Direct Sales Propel Growth in Industrial Laundry Machine Market, the Revenue to Hit $4.16 Billion by 2029 – Arizton

“Industrial Laundry Machine Market Research Report by Arizton”

 

According to Arizton’s latest research report, the industrial laundry machine market is growing at a CAGR of 5.82% from 2023 to 2029.    

 

To Know More, Click: https://www.arizton.com/market-reports/industrial-laundry-machine-market 

The industrial laundry machines market is intricately connected to global economic shifts, regional industry dynamics, and evolving consumer preferences. Traditional sectors, such as hospitality and healthcare, and emerging trends, including sustainability and technological innovation, drive the demand. As businesses worldwide recalibrate operations post-pandemic, the industrial laundry machines market remains pivotal in ensuring hygiene, efficiency, and sustainability across diverse industries. 

The growing demand for energy-efficient and water-saving machines is a significant catalyst propelling the expansion of the global industrial laundry machine market. This trend reflects a broader shift in industries toward sustainable practices and operational efficiency. The adoption of energy-efficient and water-saving machines is particularly evident in response to environmental concerns, regulatory pressures, and the desire for cost savings across various sectors relying on industrial laundry services. 

One key driver for the increased demand for energy-efficient machines is the global emphasis on sustainability. For instance, MAG Laundry Equipment recently introduced a series of industrial washing machines with capacities spanning from 25kg to 150kg. According to the company, these newly unveiled machines claim enhanced speed and reduced noise levels, potentially leading to a 60% reduction in utility expenses. The latest offerings from MAG Laundry Equipment include various drum capacities, including 25kg, 39kg, 50kg, 65kg, 85kg, and 100kg. In addition, the company provides heavy-duty commercial and industrial models ranging from 8kg to 150kg, ensuring efficient and prompt laundry processing for various needs. 

 

Direct Channel Booming the Market Sales  

The direct sales channel in the industrial laundry machine market connects manufacturers directly with end-users, providing a transparent and efficient distribution channel. This approach involves manufacturers selling their products directly to businesses without intermediaries, allowing for more personalized interaction and a direct line of communication. The scale of industrial operations influences the dynamics of the direct sales channel, the need for customization, and the importance of establishing strong client relationships. 

Countries with robust industrial and commercial sectors, such as the US, Germany, China, and Japan, significantly contribute to the global market for industrial laundry machines through direct sales channels. In these countries, the direct approach aligns with the preferences of large-scale industrial operations that often require customized solutions and personalized service. 

Countries expected to witness growth in the direct sales channel for industrial laundry machines include those with a booming industrial and commercial sector, such as countries in APAC, including India, China, and Indonesia. These countries are expected to demand tailored solutions and emphasize building strong client relationships. 

 

Notable M&A Deals in the Industrial Laundry Machine Market: 

  • 2022: Alliance Laundry Systems acquires Primus Laundry Systems, a leading provider of high-quality laundry equipment for the hospitality industry. 

  • 2021: Girbau Industrial acquires IPSO, a significant player in the industrial laundry machine market, expanding its presence in the European market. 

  • 2020: UniMac acquires Rykon, a manufacturer of automated laundry systems, to enhance its offerings in the automation segment. 

  • 2019: Speed Queen acquires Cissell Laundry Systems, a leading provider of laundry solutions for the healthcare industry, expanding its product offerings in this sector. 

 

Key Market Developments  

  • Increasing demand from healthcare, hospitality, and commercial sectors for high-quality laundry services. 

  • Rising adoption of sustainable and energy-efficient laundry equipment to reduce operating costs and environmental impact.  

  • Rising adoption of sustainable and energy-efficient laundry equipment to reduce operating costs and environmental impact. 

  • Emerging markets such as APAC and Latin America are witnessing rapid urbanization and industrialization, driving the demand for industrial laundry machines. 

 

Buy this Research @ https://www.arizton.com/market-reports/industrial-laundry-machine-market 

Post-Purchase Benefit                          

  • 1hr of free analyst discussion                         

  • 10% off on customization       

 

Key Company Profiles 

  • Alliance Laundry System 

  • Electrolux 

  • GIRBAU 

  • Herbert Kannegiesser 

  • JENSEN-GROUP 

  • Miele & Cie 

  • American Dryer 

  • ASAHI SEISAKUSHO 

  • B&C Technologies 

  • BÖWE Textile Cleaning 

  • Chicago Dryer Company 

  • DEXTER LAUNDRY 

  • EDRO Corporation 

  • Fagor Professional 

  • G.A. Braun 

  • Genist Technocracy 

  • Gottlob Stahl Wäschereimaschinenbau 

  • IFB Appliances 

  • Jiangsu Sealion Machine Group 

  • JLA Group 

  • Lapauw International 

  • Laundrylux 

  • LAVATEC LAUNDRY TECHNOLOGY 

  • Mag Laundry Equipment 

  • ONNERA GRAN LAVANDERIA 

  • Pellerin Milnor Corporation 

  • Pony 

  • TOLON 

  • VEGA Systems Group 

  • WASHCO 

  • Whirlpool 

 

Market Segmentation 

Products 

  • Washer & Extractor 

  • Dryer 

  • Ironer 

  • Folder 

  • Others 

Application 

  • Hospitality 

  • Healthcare 

  • Commercial Laundry 

  • Manufacturing 

  • Others 

Capacity 

  • Small 

  • Medium 

  • Large 

Sales Channel 

  • Direct Channel 

  • Indirect Channel 

Technology 

  • Semi-automatic 

  • Automatic 

Geography 

  • APAC 

  • China 

  • Japan 

  • India 

  • South Korea 

  • Australia 

  • Singapore 

  • The Rest of APAC 

  • Europe 

  • Germany 

  • France 

  • The UK 

  • Italy 

  • Spain 

  • Rest of Europe 

  • North America 

  • The US 

  • Canada 

  • Middle East & Africa 

  • Saudi Arabia 

  • The UAE 

  • South Africa 

  • Rest of the Middle East & Africa 

  • Latin America 

  • Brazil 

  • Mexico 

  • Argentina 

  • The Rest of Latin America 

 

Key Questions Answered in the Report:      

How big is the industrial laundry machine market? 

What is the growth rate of the global industrial laundry machine market? 

Which region dominates the global industrial laundry machine market share? 

What are the significant trends in the industrial laundry machine industry? 

Who are the key players in the global industrial laundry machine market? 

 

Check Out Some of the Top Selling Research Reports:       

Industrial Laundry Detergent Market – Global Outlook and Forecast 2021-2026 

Industrial Nailers and Staplers Market – Global Outlook & Forecast 2021-2026 

Laundry Dosing Systems Market – Global Outlook & Forecast 2022-2027 

Industrial Motors Market – Global Outlook & Forecast 2023-2028 

 

Why Arizton?                   

100% Customer Satisfaction                   

24×7 availability – we are always there when you need us                   

200+ Fortune 500 Companies trust Arizton’s report                   

80% of our reports are exclusive and first in the industry                   

100% more data and analysis                   

1500+ reports published till date         

           

About Us:                                                        

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                      

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                       

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                             

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1-312-235-2040/+1 302 469 0707     
Country: United States
Website: https://www.arizton.com/market-reports/industrial-laundry-machine-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Sustainability Drive and Direct Sales Propel Growth in Industrial Laundry Machine Market, the Revenue to Hit $4.16 Billion by 2029 – Arizton

Medical Waste Management Market to Surpass USD 14.89 Billion by 2031, Witnessing 6.2 % CAGR Growth

“Skyquest Technology”
Medical Waste Management Market Size, Share, Growth Analysis, By Type(Non-Hazardous Waste, and Hazardous Waste, Infectious & Pathological Waste (Pharmaceutical Waste, Sharp Waste), By Service(Collection, Transportation, & Storage Services, Treatment & Disposal Services (Incineration), By Treatment site(Onsite, and Offsite.), By Application(Hospitals, Retail Pharmacy, Blood Banks, Laboratories), By Region – Industry Forecast 2024-2031

Medical Waste Management Market size was valued at around USD 8.7 billion in 2022 and is poised to grow from USD 9.2 billion in 2023 to USD 14.89 billion by 2031, at a CAGR of 6.2% over the forecast period (2024–2031).

The prevalence of chronic diseases, volume of medical waste generated, increasing age population, technological advancement for better medical waste management all drives the growth of global medical waste management market.

Government initiatives to improve medical waste management are also fueling the market growth. With the growth of pharmaceutical and healthcare industries, especially in developing countries, various types of medical waste such as biosafety molds, infectious cytostatic, photochemical pathology waste and dyes grow. State-of-the-art recycling and disposal technologies are expected to provide more efficient and environmentally friendly management of medical waste in its various forms.

The pharmaceutical industry is rapidly evolving with the adoption of new methods of drug development and medical devices. Furthermore, the market expansion is reflected in the effective supply chain management of inventory required for the day-to-day operations of hospitals, clinics and facilities. Consequently, this enhanced activity contributes to increased generation of medica residues. There is a growing need for systematic and efficient initiatives to manage these sources and residues, including the collection, transportation, disposal and recycling of specific materials.

Download a detailed overview:

https://www.skyquestt.com/sample-request/medical-waste-management-market

“Navigating the Competitive Terrain: Leaders and Innovators Transforming Medical Waste Management”

The medical waste management market is characterized by diverse and competitive conditions, driven by regulatory requirements, technological advances and an increased emphasis on the sustainable practices.

Stericycle Inc.

Strategy: Stericycle also invests heavily in new technologies to enhance its waste management capabilities and ensure compliance with stringent regulations.

Contribution: Stericycle’s extensive network and expertise helps healthcare facilities manage waste effectively and reduce environmental impact.

Technological Progress and Sustainability

Autoclaving and microwave treatment: Companies are adopting advanced treatment methods such as autoclaving and microwave treatment, which are environmentally friendly compared to conventional incineration.

Request Free Customization of this report:

https://www.skyquestt.com/speak-with-analyst/medical-waste-management-market

Digital solutions: Integration of digital solutions such as waste management systems and compliance software is in progress. This technology increases transparency, improves compliance, and streamlines waste management.

Sustainability: Increased emphasis has been placed on sustainability, with companies focusing on waste reduction, recycling and resource recovery. Strategies such as reusable containers and energy-efficient production methods are gaining momentum.

In June 2023, Cabinet Health, innovators of the world’s first refillable and compostable pharmacy system, began a nationwide drug recycling campaign used in the manufacture of pharmaceutical bottles.The project aims to address the challenge of chemicals used in plastic waste production.

In January 2023, Ecosteris, a leader in healthcare waste manufacturing and disposal, unveiled a state-of-the-art medical waste product in Summerville, establishing a unique and innovative niche in the industry.

In April 2022, Stericycle, Inc. introduces its latest product, the SafeShield medical waste container, designed with a focus on high quality to safely store regulated medical waste.

View report summary and Table of Contents (TOC):

https://www.skyquestt.com/report/medical-waste-management-market

Ensuring a Sustainable Future: The Medical Waste Management Market

The medical waste management marketplace is poised for substantial growth because the demand for powerful and sustainable waste control solutions keeps growing. With the belief of environmental fitness effects of unsuitable disposal of scientific waste, felony stress and technological advancements, the marketplace is experiencing transformational modifications. Companies are focusing on the waste of the latest environmentally pleasant approaches, inclusive of improved sorting, weeding and disposal techniques. The aggregate of digital generation and automation similarly complements productivity and compliance in the field.

Related Reports:

Artificial Intelligence Market

Visit Our Website: https://www.skyquestt.com/

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email: Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/medical-waste-management-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Medical Waste Management Market to Surpass USD 14.89 Billion by 2031, Witnessing 6.2 % CAGR Growth

Artificial Intelligence (AI) in Healthcare Market worth $148.4 Billion by 2029, at a CAGR of 48.1%

“Artificial Intelligence (AI) in Healthcare Market”
The global Artificial Intelligence (AI) in Healthcare Market in terms of revenue was estimated to be worth $20.9 billion in 2024 and is poised to reach $148.4 billion by 2029, growing at a CAGR of 48.1% during the forecast period.

The report “Artificial Intelligence (AI) in Healthcare Market by Offering (Hardware, Software, Services), Technology (Machine Learning, Natural Language Processing), Application (Medical Imaging & Diagnostics, Patient Data & Risk Analysis), End User & Region – Global Forecast to 2029” The AI in Healthcare industry is projected to grow from USD 20.9 billion in 2024 and is estimated to reach USD 148.4 billion by 2029; it is expected to grow at a Compound Annual Growth Rate (CAGR) of 48.1% from 2024 to 2029. The growth of the AI in Healthcare industry is driven by the growing need for improvised healthcare services due to the imbalance between the healthcare workforce and patients; improving computing power, and declining hardware cost.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54679303

Browse 206 market data Tables and 70 Figures spread through 291 Pages and in-depth TOC on “Artificial Intelligence (AI) in Healthcare Market by Offering (Hardware, Software, Services), Technology (Machine Learning, Natural Language Processing), Application (Medical Imaging & Diagnostics, Patient Data & Risk Analysis), End User & Region – Global Forecast to 2029”

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-healthcare-market-54679303.html

Artificial Intelligence (AI) in Healthcare Market

By offering, the services are projected to grow at a high CAGR of AI in healthcare industry during the forecast period.

AI plays a pivotal role across diverse healthcare applications, necessitating the implementation of sophisticated algorithms for tasks ranging from patient data analysis to drug discovery. Its applications span patient care, risk analysis, lifestyle management, precision medicine, medical imaging, and more. Successful AI deployment hinges on comprehensive services such as deployment, integration, and ongoing support and maintenance. Key players in the AI services in the healthcare industry, including Microsoft, Johnson & Johnson Services, Medtronic, Siemens Healthineers, and Koninklijke Philips, offer a spectrum of support services. These encompass online and offline assistance, installation, training, and post-maintenance, ensuring seamless integration and optimal functioning of AI systems in the dynamic healthcare landscape.

Machine learning technology in AI in healthcare industry is expected to account for the largest share during the forecast period.

Machine learning revolutionizes computing by training systems to learn from data without explicit programming. Instead of predefined instructions, machine learning relies on algorithms to discern patterns and relationships in data, enhancing accuracy and performance with increased exposure to information. Key attributes include data-driven processes, adaptability to new data, and the absence of explicit programming. In healthcare, machine learning intersects with AI, offering transformative applications. It aids in medical diagnosis and imaging by detecting diseases in early stages through image analysis and predicting risks based on electronic health records. Additionally, it accelerates drug discovery, optimizes administrative tasks, and enhances public health initiatives by tracking outbreaks and identifying high-risk individuals. Despite its potential, challenges like data privacy, algorithmic bias, and ethical considerations underscore the importance of careful integration and human oversight in the evolving healthcare landscape shaped by machine learning.

By segment, AI in healthcare industry for Medical Imaging & Diagnostics segment will account for highest CAGR during the forecast period.

AI is reshaping medical imaging and diagnostics, steering in a new era of precision and efficiency. By employing super-resolution techniques, AI reconstructs lower-resolution medical images into highly detailed visuals, aiding in more accurate diagnoses. Automated image analysis and detection capabilities enable AI algorithms to swiftly identify abnormalities, such as tumors or fractures, streamlining the diagnostic process. Moreover, AI’s role in personalized medicine is pivotal, predicting disease risks and treatment responses, and even assisting in surgical planning. This transformative technology enhances the accuracy of diagnoses and contributes to more efficient workflows, improved accessibility to diagnostics, and the potential for personalized treatment strategies.

Asia Pacific will account for the highest CAGR during the forecast period.

The increasing geriatric population in Asia Pacific countries is one of the major drivers for the growth of the AI in healthcare industry. According to the United Nations ESCAP report 2023 a significant demographic shift in Asia and the Pacific, projecting that the older population will surpass 1.3 billion by 2050, doubling from 630 million in 2020. In 2020, 13.6% of the region’s population was aged 60 or above, a figure expected to rise to one-quarter by 2050. According to the National Library of Medicine, 2023. In 2017, the Asia-Pacific region had 9.8% of its total population comprised of older adults. Projections indicate a rise to 13.7% by 2030 and a further increase to 20.3% by 2050. Notably, Japan, China, and Hong Kong are poised to lead globally with the highest percentage of individuals aged 80 and above.

AI in Healthcare Industry: Key players

Key companies operating in the AI in healthcare industry are Koninklijke Philips N.V. (Netherlands), Microsoft (US), Siemens Healthineers AG (Germany), Intel Corporation (US), NVIDIA Corporation (US), Google Inc. (US), GE HealthCare Technologies Inc. (US), Oracle (US), and Johnson & Johnson Services, Inc. (US) among others.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-healthcare-market-54679303.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Artificial Intelligence (AI) in Healthcare Market worth $148.4 Billion by 2029, at a CAGR of 48.1%

Thyroid Cancer Drugs Pipeline 2024 | AffyImmune Therapeutics, Suzhou Zelgen Biopharmaceuticals, Bristol-Myers Squibb, Suzhou NeuPharma, AstraZeneca, Verastem Oncology, Thryv Therapeutics, Molecular Ta

DelveInsight’s, “Thyroid Cancer Pipeline Insight 2024” report provides comprehensive insights about 50+ companies and 51+ pipeline drugs in Thyroid Cancer pipeline landscape. It covers the Thyroid Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Explore our latest breakthroughs in Thyroid Cancer Research. Learn more about our innovative pipeline today! @ Thyroid Cancer Pipeline Outlook

 

Key Takeaways from the Thyroid Cancer Pipeline Report

  • August 2024:- Novarits Pharmaceuticals- A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer (DTC)
  • DelveInsight’s Thyroid Cancer pipeline report depicts a robust space with 50+ active players working to develop 51+ pipeline therapies for Thyroid Cancer treatment.
  • The leading Thyroid Cancer Companies such as AffyImmune Therapeutics, Suzhou Zelgen Biopharmaceuticals, Bristol-Myers Squibb, Suzhou NeuPharma, AstraZeneca, Verastem Oncology, Thryv Therapeutics, Molecular Targeting Technologies, Chimerix, Codiak BioSciences, LeadArtis, Tyra Biosciences, Roche, Sichuan Kelun-Biotech Biopharmaceutical, Advenchen Laboratories, and others.
  • Promising Thyroid Cancer Therapies such as Selpercatinib, Cabozantinib, Vandetanib, E7080 Capsule, Lenvatinib (DTC Cohort), Irofulven + capecitabine, XL184, AL2846 Capsule, and others.

 

Stay informed about the cutting-edge advancements in Thyroid Cancer Treatments. Download for updates and be a part of the revolution in cancer care @ Thyroid Cancer Clinical Trials Assessment

 

Thyroid Cancer Emerging Drugs

  • rhTSH: Suzhou Zelgen Biopharmaceuticals

Recombinant human TSH (rhTSH) was developed to provide TSH stimulation without the requirement for THST withdrawal and the resultant metabolic disturbance, and without the drawbacks associated with the use of bovine TSH. The drug is currently being evaluated under Phase III clinical trial for the treatment of patients with thyroid cancer.

  • Nivolumab: Bristol-Myers Squibb

Nivolumab is a human immunoglobulin G4 (IgG4) monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with PD-L1 and PD-L2, releasing PD-1 pathway-mediated inhibition of the immune response, including the anti-tumor immune response. The drug is currently being evaluated under Phase II clinical trial for the treatment of patients with thyroid cancer.

  • RX208: Suzhou NeuPharma

RX208 is a potential “best-in-class” BRAF V600E inhibitor with a proprietary novel chemical structure that is different from other marketed BRAF inhibitors. It exhibited high bioavailability and excellent anti-tumor efficacy in preclinical studies. Early clinical data demonstrated preliminary efficacy and good safety and tolerability in patients with cancer, warranting further clinical development. The drug is currently being evaluated under Phase I/II clinical trial for the treatment of patients with thyroid cancer.

  • AIC100: AffyImmune Therapeutics

AffyImmune’s lead product, AIC100, is an affinity-tuned, ICAM-1 targeted, third generation CAR T cell therapy. AIC100’s CAR has an affinity to ICAM-1 similar to the affinity between naturally-occurring T cells and their targets, which is much lower than most CARs used to date and reduces on-target off-tumor toxicities. AIC100 also expresses SSTR2 for real-time monitoring of CAR T cell distribution and activity. Preclinical studies demonstrate that AIC100 induces robust and enduring tumor eradication without toxicity-related relapse or fatality in various solid tumor models. Studies also suggest the potential for combination with anti-PD-1 therapies. The drug is currently being evaluated under Phase I clinical trial for the treatment of patients with Thyroid Cancer.

 

Learn more about Thyroid Cancer Drugs opportunities in our groundbreaking Thyroid Cancer Research and development projects @ Thyroid Cancer Unmet Needs

 

Thyroid Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

  • Intravenous
  • Subcutaneous
  • Oral
  • Intramuscular

 

Thyroid Cancer Products have been categorized under various Molecule types such as

  • Monoclonal antibody
  • Small molecule
  • Peptide

 

Discover the latest advancements in Thyroid Cancer Treatment by visiting our website. Stay informed about how we’re transforming the future of oncology @ Thyroid Cancer Market Drivers and Barriers, and Future Perspectives

 

Thyroid Cancer Drugs and Companies

  • Rosiglitazone: Exelixis
  • Lenvatinib: Eisai Limited
  • Ifosfamide: Merck Sharp & Dohme LLC

 

Scope of the Thyroid Cancer Pipeline Report

  • Coverage- 7MM
  • Thyroid Cancer Companies such as AffyImmune Therapeutics, Suzhou Zelgen Biopharmaceuticals, Bristol-Myers Squibb, Suzhou NeuPharma, AstraZeneca, Verastem Oncology, Thryv Therapeutics, Molecular Targeting Technologies, Chimerix, Codiak BioSciences, LeadArtis, Tyra Biosciences, Roche, Sichuan Kelun-Biotech Biopharmaceutical, Advenchen Laboratories, and others.
  • Thyroid Cancer Therapies- Selpercatinib, Cabozantinib, Vandetanib, E7080 Capsule, Lenvatinib (DTC Cohort), Irofulven + capecitabine, XL184, AL2846 Capsule, and others.
  • Thyroid Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Thyroid Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

For a detailed overview of our latest research findings and future plans, read the full details of Thyroid Cancer Pipeline on our website @ Thyroid Cancer Drugs and Companies

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Thyroid Cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Thyroid Cancer– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. rhTSH: Suzhou Zelgen Biopharmaceuticals
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. Nivolumab: Bristol-Myers Squibb
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. AIC100:Affyimmune Therapeutics
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. Drug name: Company name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Thyroid Cancer Key Companies
  21. Thyroid Cancer Key Products
  22. Thyroid Cancer- Unmet Needs
  23. Thyroid Cancer- Market Drivers and Barriers
  24. Thyroid Cancer- Future Perspectives and Conclusion
  25. Thyroid Cancer Analyst Views
  26. Thyroid Cancer Key Companies
  27. Appendix 

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Thyroid Cancer Drugs Pipeline 2024 | AffyImmune Therapeutics, Suzhou Zelgen Biopharmaceuticals, Bristol-Myers Squibb, Suzhou NeuPharma, AstraZeneca, Verastem Oncology, Thryv Therapeutics, Molecular Ta

The Decorative Films and Foils Market to Hit USD 3.91 billion by 2029, Innovation of Solar-Powered Advancements Creating Huge Market Expansion – Arizton

“Decorative Films And Foils Market Research Report by Arizton”

According to Arizton’s latest research report, the global decorative films and foils market is growing at a CAGR of 4.52% 2023-2029.    

 

To Know More, Click: https://www.arizton.com/market-reports/decorative-films-and-foils-market 

 

Automotive Industry Gaining Momentum in the Decorative Films and Foils Market 

Decorative films and foils are crucial in enhancing vehicle interiors’ security, privacy, and aesthetics. Installed on the interior surfaces of vehicles, these films contribute to an appealing glossy look and high transparency while ensuring improved passenger or owner privacy. Lighter-tinted car decorative films and foils reduce fading, offer uninterrupted heat rejection, and enhance the overall appearance of a vehicle. Automotive decorative films are valuable in reducing heat loss in winter, gaining solar heat, and maintaining a sustainable and high comfort level inside the vehicle. Furthermore, UV-filtering dyeing films decrease the risk of skin cancer and damage. These films also block more than 90%-95% of Ultraviolet rays, providing more comfort to users by preventing undesirable sun glare. Thus, the ability of automobile decorative films to protect the exterior of the car is another factor driving revenue growth in the market. 

 

Offline Distribution Channel Leading the Market Expansion  

In 2023, the offline distribution channel, holding a revenue share of 61.33%, is anticipated to dominate sales in the global decorative films and foils market. The continued prominence of offline channels persists in mitigating the risk of product damage, particularly concerning decorative films and foils and their associated costs. Despite the growing trend of online sales, a significant portion of distribution for these products occurs through specialty stores. Producers of decorative films and foils capitalize on the personalized customer service offered by specialty stores and supermarkets. 

Moreover, the online channel holds a relatively lower market share but is expected to witness the highest segmental CAGR during the forecast period. The proliferation of e-commerce and a rise in the awareness of the benefits of online purchases, such as heavy discounts, occasional offers, and convenience, drive the growth of the online segment. Furthermore, high penetration rates are expected for online multichannel platforms, and vendors are expected to grow their online presence through their e-commerce platforms and collaborations with other e-commerce firms during the forecast period. 

 

Growing Popularity of Solar Films and Foils Creating Immense Opportunities for Vendors  

Solar control window films, blocking 90% to 95% of harmful UVA and UVB radiation, offer consumers flexibility in various shades and sizes. Adjustable thickness affects light transmission levels (3% to 70%), safeguarding vehicle interiors and extending their lifespan by preventing direct sunlight entry. The rising adoption of sun-controlled decorative films, driven by skin disease prevention needs, is augmented by adverse atmospheric conditions in regions like India, the UAE, Brazil, and Mexico. Healthcare industries increasingly use solar control films, with specialized offerings like Kling Shield’s reflective sun control window film ensuring light entry and interior visibility. The automotive sector witnesses heightened demand for heat dissipation solutions, propelling decorative film adoption. Technological advancements, notably multilayer nanotechnology, enhance product performance, driving market growth. Rapid industrialization, urbanization, and growing disposable incomes generate global demand for decorative films. Increased passenger vehicle demand, particularly in developed economies, and rising per capita incomes are expected to fuel solar control decorative film growth in the foreseeable future. 

 

Buy this Research @ https://www.arizton.com/market-reports/decorative-films-and-foils-market 

 

Post-Purchase Benefit                             

  • 1hr of free analyst discussion                            

  • 10% off on customization   

 

Key Company Profiles 

  • Eastman 

  • 3M Company 

  • LINTEC Corporation 

  • LG Hausys 

  • Madico 

  • RENOLIT 

  • Klockner Pentaplast 

  • OMNOVA Solutions 

  • Grafix Plastics 

  • Dumore Corporation 

  • Avery Dennison Corporation 

  • Peiyu Plastic Corporation 

  • ORAFOL Group 

  • Sun Process Converting, Inc. 

  • RASIK PRODUCTS PVT. LTD. 

  • Yodean Decor 

  • Decorative Films, LLC 

  • America Standard Window Films 

  • Armolan Window Films 

  • Toray Plastics 

  • Saint-Gobain Performance Plastics Corporation 

 

Market Segmentation 

Category Type 

  • Adhesive 

  • Non-adhesive 

Material Type 

  • PVC 

  • PET 

  • PP 

  • Others 

Product Type 

  • Frosted 

  • Architectural 

  • Vinyl 

  • Others 

Technology 

  • Metalized 

  • Ceramic 

  • Dyed 

  • Others 

Usage Type 

  • Indoor 

  • Outdoor 

End-user 

  • Commercial 

  • Residential 

  • Automotive 

  • Marine 

  • Others 

Distribution Channel 

  • Offline 

  • Online 

Geography 

  • North America 

  • The US 

  • Canada 

  • Europe 

  • The UK 

  • Germany 

  • France 

  • Russia 

  • Italy 

  • Spain 

  • Netherlands 

  • Belgium 

  • APAC 

  • China 

  • Japan 

  • India 

  • Australia 

  • South Korea 

  • Latin America 

  • Brazil 

  • Mexico 

  • Argentina 

  • Middle East & Africa 

  • South Africa 

  • Saudi Arabia 

  • The UAE 

  • Turkey 

 

Key Questions Answered in the Report:   

How big is the decorative films and foils market? 

What is the growth rate of the global decorative films and foils market? 

Which region dominates the global decorative films and foils market share? 

What are the significant trends in the decorative films and foils industry? 

Who are the key players in the global decorative films and foils market? 

 

Why Arizton?                      

100% Customer Satisfaction                      

24×7 availability – we are always there when you need us                      

200+ Fortune 500 Companies trust Arizton’s report                      

80% of our reports are exclusive and first in the industry                      

100% more data and analysis                      

1500+ reports published till date                       

 

About Us:                                                           

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                         

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                          

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                                

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1-312-235-2040 /+1 302 469 0707  
Country: United States
Website: https://www.arizton.com/market-reports/decorative-films-and-foils-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Decorative Films and Foils Market to Hit USD 3.91 billion by 2029, Innovation of Solar-Powered Advancements Creating Huge Market Expansion – Arizton

Pain Management Devices Market Forecast to Grow at 21.5% CAGR from 2024 to 2031 | SkyQuest Technology

“Skyquest Technology”
Pain Management Devices Market Size, Share, Growth Analysis, By Product(Electrical Stimulators, Radiofrequency Ablation (RFA), Analgesic Infusion Pumps, and Neurostimulation), By Application(Cancer, Neuropathic Pain, Facial & Migraine, Musculoskeletal Disorder), By Region – Industry Forecast 2024-2031

Pain Management Devices Market size was valued at around USD 12.76 billion in 2022 and is expected to rise from USD 15.50 billion in 2023 to reach a value of USD 73.7 billion by 2031, at a CAGR of 21.5% over the forecast period (2024–2031).

Pain management devices are medical devices specifically designed to help control pain. These devices are intended to be used as part of a comprehensive pain management program and can provide relief for various types of pain, including chronic, acute, and postoperative pain.

Pain management devices, especially those involving implants or implantable procedures, are subject to rigorous regulatory scrutiny to ensure safety and effectiveness. Probably pain management devices will not be equally accessible in all communities due to variations in health care. Furthermore, pain management devices can be expensive, especially advanced neuromuscular implants and drug delivery systems.

Competitive Landscape of the Pain Management Devices Market

Key players and their strategies

Download a detailed overview:

https://www.skyquestt.com/sample-request/pain-management-devices-market

Medtronic Plc

Overview: Medtronic is a leading company in the pain management device market, known for its advanced neuromuscular technology.

Strategy: The Company will continue to focus on innovation, extensive clinical trials and strategic expansion of its product portfolio and market.

Recent developments: Medtronic recently launched a new spinal stimulation program and has been actively engaged in research to improve its devices.

Boston Science Corporation: Expanding Horizons

Overview: Boston Scientific is a leading competitor, offering a wide range of pain management solutions, including spinal stimulation and radiofrequency ablation programs.

Strategy: The company’s growth strategy includes product diversification, strategy, and a strong emphasis on R&D.

Recent developments: Boston Scientific is expanding its footprint worldwide and introducing several new products to address a variety of pain conditions.

Request Free Customization of this report:

https://www.skyquestt.com/speak-with-analyst/pain-management-devices-market

Analyze the Business Verticals in the Pain Management Devices Market

Overview: Muscle-modifying devices, such as spinal stimulators and peripheral nerve stimulators, are important in the management of chronic pain by modulating muscle activity. These devices are designed to conduct the electrical current specific areas of the nerve to alter pain signals and muscle pain, chronic back pain, complex regional pain syndromes etc. to provide relief to patients suffering from various conditions.

Driving Factors: Technological advances, increased prevalence of chronic pain conditions, and increased preference for non-opioid pain relievers are the major drivers of this segment.

In May 2024, the FDA has approved Medtronic’s closed-loop rechargeable spinal cord stimulator (SCS), Inceptiv, as a new treatment for chronic pain. This approval makes the SCS device the first in the market to use a closed-loop device that senses biological signals around the spine. This stimulator will automatically change the stimulation in real time and improve the treatment and life in the day-to-day activities.

In April 2024, triCure launched the cryoSPHERE+ cryoablation probe, a device designed to improve postoperative pain management. This new probe features advanced insulation technology that reduces freeze times by 25% compared to the legacy cryoSPHERE device.  

View report summary and Table of Contents (TOC):

https://www.skyquestt.com/report/pain-management-devices-market

Paving the Way for Effective Relief: The Future of Pain Management Devices

The pain management devices market is poised for tremendous growth, driven by technological advances, aging population, and increasing chronic pain conditions. Innovations in tissue modification, pumping into the body, and into the analgesic system, improve the convenience and efficacyof preventive analgesia. As patient demand for non-opioid pain relievers increases, the market is likely to see expanded use of these devices. Legal assistance and payment processing is also expected to play an important role in the market expansion. Through continuous research and development, the pain management devices market is destined to provide effective, convenient and safe pain management solutions, providing a bright future for patients and healthcare professionals.

Related Reports:

3D Printing Market

Visit Our Website: https://www.skyquestt.com/

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email: Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/pain-management-devices-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Pain Management Devices Market Forecast to Grow at 21.5% CAGR from 2024 to 2031 | SkyQuest Technology

Dental Bone Graft Substitutes Market Worth $1.8 billion | MarketsandMarkets™

“Europe accounted for the second-largest share of dental bone graft substitute. The apidly aging population, leading to a higher demand for dental bone graft substitute is driving the growth of dental bone graft substitute in the European region.”
Dental Bone Graft Substitutes Market in terms of revenue was estimated to be worth $1.3 billion in 2024 and is poised to reach $1.8 billion by 2029, growing at a CAGR of 7.7% from 2024 to 2029 according to a new report by MarketsandMarkets™.

 Dental Bone Graft Substitutes Market in terms of revenue was estimated to be worth $1.3 billion in 2024 and is poised to reach $1.8 billion by 2029, growing at a CAGR of 7.7% from 2024 to 2029 according to a new report by MarketsandMarkets™.

The global population is growing older, leading to an increased demand for dental bone graft substitute also the increasing popularity of dental implants as a tooth replacement option creates a direct need for bone graft substitutes which is expected to drive the market growth. However, high material costs and surgical costs associated with hospital or clinic fees, surgeon fees, and anesthesia is expected to challenge the growth of the market.

This report divides dental bone graft substitute into four segments – type, application, mechanism, product, end user and region.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159678690

“Based on dental bone graft substitute by end user, the hospitals segment is expected to grow at the highest CAGR during the forecast period.”

Under end user, hospital segment is forecasted to grow at the highest CAGR from 2024 to 2029., Bone grafting is frequently used in hospitals for oral and maxillofacial surgery for procedures like jaw reconstruction, alveolar ridge preservation, cleft lip and palate repair and dental implantology, when natural jawbone is insufficient for implant placement, bone grafts provide a foundation for successful implant osseointegration (fusion with bone).

“The Bio-Oss segment is expected to account for the largest share, by product in dental bone graft substitute.”

By product segment, dental bone graft substitute is segmented into Bio-Oss, osteograf, grafton and others. Bio-Oss accounts for the largest share in by product category. Bio-Oss has a long history of successful use in dental bone grafting procedures, with extensive clinical research supporting its efficacy and safety which is expected to drive the segment growth.

“The osteoconduction segment is expected to account for the largest share, by mechanism in dental bone graft substitute.”

By mechanism segment, dental bone graft substitute is segmented into bio osteoconduction, osteoinduction, osteopromotion, osteogenesis. osteoconduction accounts for the largest share in by mechanism category. Osteoconduction promotes bone regeneration at the defect site, provides a foundation for dental implant placement and supports jawbone structure and prevents collapse which is expected to drive the segment growth.

“In 2023, Europe was the region with the second largest market share in dental bone graft substitute. “

Dental bone graft substitute is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa and GCC countries.

Europe accounted for the second-largest share of dental bone graft substitute in 2023. The apidly aging population, leading to a higher demand for dental bone graft substitute is driving the growth of dental bone graft substitute in the European region.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=159678690

Dental Bone Graft Substitutes Market Dynamics:

Drivers:

  1. Rising aging population

Restraints:

  1. Stringent regulatory guidelines for medical devices

Opportunities:

  1. Growing Prevalence of Dental Disorders

Challenge:

  1. High Surgical Procedures Costs

Key Market Players of Dental Bone Graft Substitutes Industry:

Key players in dental bone graft substitute include Dentsply Sirona Inc. (US), Envista Holdings Corporation (US), JOHNSON & JOHNSON (US), Stryker Corporation (US), Medtronic, Plc (Ireland), Institut Straumann AG (Switzerland),  Zimvie Inc. (US), Henry Schein Inc. (US), RTI Surgical Holdings Inc.(US), Lifenet Health (US), Dentium (US), Geistlich Pharma AG (Switzerland), Integra Lifesciences Holdings Corporation (US), Tissue Regenix Group (UK), Kuraray Co. Ltd. (Japan), BEGO GmbH & Co. KG (Germany), Young Innovations (US), Keystone Dental (US), Novabone LLC. (US), Biotiss Biomaterials LLC (US), Collagen Matrix Inc.(US), Osteogenics Biomedical (US), Hannox International Corp.(Taiwan), Meyer Haake GMBH (Germany) and  Arora Biosurgery Ltd. (New Zealand).

A breakdown of the primary participants (supply-side) for the dental bone graft substitute market referred to for this report is provided below:

  • By Company Type: Tier 40%, Tier 35%, and Tier 25%
  • By Designation: C-level–30%, Director Level–55%, and Others–15%
  • By Region: North America–20%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East & Africa-30%.

Get 10% Free Customization on this Report:https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=159678690

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: Switzerland
Website: https://www.prnewswire.com/news-releases/dental-bone-graft-substitutes-market-worth-1-8-billion–marketsandmarkets-302131562.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Dental Bone Graft Substitutes Market Worth $1.8 billion | MarketsandMarkets™

Wet Age-Related Macular Degeneration Pipeline 2024 | OliX Pharmaceuticals, Frontera Therapeutics, Kyowa Kirin, Boehringer Ingelheim, Clearside Biomedical, PanOptica, EyePoint Pharmaceuticals

DelveInsight’s, “Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Insight, 2024,” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Wet Age-Related Macular Degeneration (Wet-AMD) pipeline landscape. It covers the Wet Age-Related Macular Degeneration pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Wet Age-Related Macular Degeneration therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Explore our latest breakthroughs in Wet Age-Related Macular Degeneration Research. Learn more about our innovative pipeline today! @ Wet Age-Related Macular Degeneration Pipeline Outlook

 

Key Takeaways from the Wet Age-Related Macular Degeneration Pipeline Report

  • August 2024:- Outlook Therapeutics Inc.:- Safety and Effectiveness of ONS-5010 Compared to Lucentis® in Subjects With Neovascular Age-related Macular Degeneration; NORSE EIGHT. Multicenter, randomized, masked, controlled study of the safety and effectiveness of intravitreally administered ONS-5010.
  • DelveInsight’s Wet Age-Related Macular Degeneration pipeline report depicts a robust space with 70+ active players working to develop 75+ pipeline therapies for Wet Age-Related Macular Degeneration treatment.
  • The leading Wet Age-Related Macular Degeneration Companies such as OliX Pharmaceuticals, Frontera Therapeutics, Kyowa Kirin, Boehringer Ingelheim, Clearside Biomedical, PanOptica, EyePoint Pharmaceuticals, Unity Biotechnology, AngioLab, Kinarus Therapeutics, Sylentis, Mabwell (Shanghai) Bioscience, Samsung Bioepis, Sandoz, Outlook Therapeutics, Molecular Partners, Sam Chun Dang Pharm, TOT Biopharm, and others.
  • Promising Wet Age-Related Macular Degeneration Pipeline Therapies in the various stages of development include Aflibercept (Eylea, BAY86-5321), Eyp-1901, NG101 AAV gene therapy, CMAB818, Lucentis®, RC28-E, Aflibercept, Ranibizumab, SCT510A, SCD411, Aflibercept, and others.

 

Stay informed about the cutting-edge advancements in Wet Age-Related Macular Degeneration Treatments. Download for updates and be a part of the revolution in cancer care @ Wet Age-Related Macular Degeneration Clinical Trials Assessment

 

Wet Age-related Macular Degeneration Emerging Drugs

  • RGX-314: REGENXBIO

RGX-314 is a one-time subretinal treatment that includes the NAV AAV8 vector containing a gene encoding for a monoclonal antibody fragment. The expressed protein is designed to neutralize vascular endothelial growth factor (VEGF) activity, modifying the pathway for the formation of new leaky blood vessels and retinal fluid accumulation. RGX-314 is being developed as a potentially one-time treatment for wet AMD, diabetic retinopathy, and other additional chronic retinal conditions treated with anti-VEGF.

  • 9MW 0211: Mabwell (Shanghai) Bioscience

9MW 0211 is a recombinant anti-VEGF humanized monoclonal antibody obtained based on rabbit monoclonal antibody and humanized transformation technology, which is a category 1 therapeutic biological product. It can specifically bind to the most active VEGF-A in the VEGF family, block its binding to receptors on the surface of endothelial cells, reduce vascular permeability and block the formation and development of new blood vessels, and reduce the leakage caused by new blood vessels, so as to achieve the purpose of treating eye diseases related to neovascularization such as neovascular (wet) age-related macular degeneration. The drug is currently being evaluated in Phase II/III clinical trial to treat patients with wet-AMD.

  • SYL1801: Sylentis

SYL1801 is a chemically modified siRNA, engineered using Sylentis proprietary SirFinder, which inhibits the synthesis of Nrarp. It is administered as an eye drop solution to transcriptionally down-regulate the expression of Nrarp, a target different from those against which the usual anti-angiogenic therapies based on anti-VEGF agents are directed. The drug is currently being evaluated under Phase II clinical trial for the treatment of patients with wet AMD.

  • OLX10212: OliX Pharmaceuticals

OLX10212 is a novel cell penetrating asymmetric small interference RNA being developed by OliX Pharmaceuticals in Phase I stage of development for the treatment of wet-MAD. OLX10212 targets inflammation pathways that play a key role in the development of geographic atrophy (GA) and neovascular AMD.

 

Learn more about Wet Age-Related Macular Degeneration Drugs opportunities in our groundbreaking Wet Age-Related Macular Degeneration Research and development projects @ Wet Age-Related Macular Degeneration Unmet Needs

 

Wet Age-related Macular Degeneration pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

  • Intravenous
  • Subcutaneous
  • Oral
  • Intramuscular

 

Wet Age-Related Macular Degeneration Products have been categorized under various Molecule types such as

  • Monoclonal antibody
  • Small molecule
  • Peptide

 

Discover the latest advancements in Wet Age-Related Macular Degeneration Treatment by visiting our website. Stay informed about how we’re transforming the future of oncology @ Wet Age-Related Macular Degeneration Market Drivers and Barriers, and Future Perspectives

 

Wet Age-Related Macular Degeneration Companies and Therapies

  • Neuracle Genetics Inc.: NG101 AAV gene therapy
  • RemeGen Co. Ltd:- RC28-E
  • Outlook Therapeutics Inc.:- Bevacizumab/Ranibizumab

 

Scope of the Wet Age-Related Macular Degeneration Pipeline Report

  • Coverage- Global
  • Wet Age-Related Macular Degeneration Companies- OliX Pharmaceuticals, Frontera Therapeutics, Kyowa Kirin, Boehringer Ingelheim, Clearside Biomedical, PanOptica, EyePoint Pharmaceuticals, Unity Biotechnology, AngioLab, Kinarus Therapeutics, Sylentis, Mabwell (Shanghai) Bioscience, Samsung Bioepis, Sandoz, Outlook Therapeutics, Molecular Partners, Sam Chun Dang Pharm, TOT Biopharm, and others.
  • Wet Age-Related Macular Degeneration Pipeline Therapies- Aflibercept (Eylea, BAY86-5321), Eyp-1901, NG101 AAV gene therapy, CMAB818, Lucentis®, RC28-E, Aflibercept, Ranibizumab, SCT510A, SCD411, Aflibercept, and others.
  • Wet Age-Related Macular Degeneration Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Wet Age-Related Macular Degeneration Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

For a detailed overview of our latest research findings and future plans, read the full details of Wet Age-Related Macular Degeneration Pipeline on our website @ Wet Age-Related Macular Degeneration Drugs and Companies

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Wet Age-related Macular Degeneration: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Wet Age-related Macular Degeneration– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. RGX-314: REGENXBIO
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. SYL1801: Sylentis
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. OLX10212: OliX Pharmaceuticals
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. Drug Name: Company Name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Wet Age-related Macular Degeneration- Unmet Needs
  21. Wet Age-related Macular Degeneration- Market Drivers and Barriers
  22. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Wet Age-Related Macular Degeneration Pipeline 2024 | OliX Pharmaceuticals, Frontera Therapeutics, Kyowa Kirin, Boehringer Ingelheim, Clearside Biomedical, PanOptica, EyePoint Pharmaceuticals